The unwinding related section 1902(e)(14) strategies newly available to Medicaid and CHIP agencies can provide significant relief to states facing pending eligibility and enrollment actions and processing delays, workforce and systems limitations, and other operational challenges. Ensuring eligible individuals do not lose coverage for procedural or administrative reasons and supporting those who are ineligible for Medicaid/CHIP transition to Marketplace coverage will be paramount for all states as they begin to resume normal operations when the federal public health emergency (PHE) ends. This expert perspective outlines the time-limited targeted enrollment flexibilities that CMS has availed to states through section 1902(e)(14) waiver authority and discusses considerations beyond the strategies described in federal guidance and supplemental resources.
The COVID-19 Relief Package and the “No Surprises Act”: Implications for States
In the waning days of 2020, Congress enacted a $900 billion COVID-19 relief package and government funding bill. Included in the measure is the “No Surprises Act,” which contains new protections for consumers from surprise medical bills from out-of-network providers. State Health & Value Strategies hosted a webinar during which experts from Georgetown University’s Center on Health Insurance Reforms, Manatt Health, and tax expert Jason Levitis reviewed the provisions of this legislation and their implications for states. The webinar reviewed the No Surprises Act and provided an overview of the next steps for implementing the federal balance billing protections and what the law will mean for state-level protections. Additionally, presenters discussed a number of other key health care provisions, including state and locality funding for COVID-19 vaccine distribution and testing as well as policy changes to the Provider Relief Fund, and the impact of additional unemployment compensation and relief payments on eligibility for financial assistance for health coverage.